Identification of two novel RHO mutations in Chinese retinitis pigmentosa patients

色素性视网膜炎 遗传学 鉴定(生物学) 生物 眼科 医学 视网膜 植物
作者
Juan Wang,Ding Xu,Tong Zhu,Yue Zhou,Xin Chen,Fang Wang,Jieping Zhang,Haibin Tian,Furong Gao,Jingfa Zhang,Caixia Jin,Jingying Xu,Lixia Lü,Qin Liu,Guo‐Tong Xu
出处
期刊:Experimental Eye Research [Elsevier BV]
卷期号:188: 107726-107726 被引量:8
标识
DOI:10.1016/j.exer.2019.107726
摘要

Retinitis pigmentosa (RP) is a group of genetically heterogeneous retinal diseases with more than 80 identified causative genes to date. Mutations in the RHO (rhodopsin, OMIM, 180380) are the most common cause of autosomal dominant RP (adRP) worldwide. RHO is also one of the few RP genes that can cause autosomal recessive RP (arRP). To explore the frequency of RP mutations in Chinese populations, panel-based NGS (next-generation sequencing) screening and Sanger sequencing validation were performed for RP patients from 72 unrelated Chinese families. Here we reported the identified mutations only in the RHO gene. Our results showed that 4 mutations in RHO were detected in 5 (6.94%) of the 72 RP families, including two known missense mutations, c.158C > G (p.P53R) and c.551A > C (p.Q184P), and two novel mutations, c.34delC (p.P12NA) and c.82C > T (p.Q28X). The c.34delC (p.P12NA) mutation was detected in heterozygous state in one patient with intermediate RP phenotype. The c.82C > T (p.Q28X) mutation was found in a homozygous state in one proband with advanced RP phenotype at the age of 32. Clinical examination of the heterozygous carriers of c.82C > T (p.Q28X) in that family showed that the father at the age of 60s experienced no symptoms of RP and normal fundus examinations but displayed reduced electroretinography (ERG) and abnormal visual field. The sister and brother at the age of 30s showed no typical aspects of RP phenotypes. Our results not only expand the mutation spectrum of the RHO gene, but also suggest that the 2 null mutations might play minor dominant effects, leading to less severe and slower retinal degeneration in heterozygous state and more severe phenotype in homozygous state.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
qintian0550给qintian0550的求助进行了留言
1秒前
鲤鱼蓝天完成签到,获得积分10
1秒前
科研通AI6.1应助董事长采纳,获得10
1秒前
DDvicky发布了新的文献求助10
2秒前
Jw完成签到,获得积分10
3秒前
虎啊虎啊发布了新的文献求助10
3秒前
aveturner完成签到,获得积分10
3秒前
尊敬亦寒发布了新的文献求助10
3秒前
妮妮完成签到 ,获得积分10
3秒前
hrd完成签到,获得积分10
4秒前
yulian完成签到,获得积分10
4秒前
科研小白完成签到,获得积分10
5秒前
莉莉子发布了新的文献求助10
5秒前
Atao完成签到,获得积分10
6秒前
7秒前
呀哈磊完成签到,获得积分10
7秒前
lyb1853完成签到 ,获得积分10
8秒前
wh完成签到,获得积分10
8秒前
虎啊虎啊完成签到,获得积分10
9秒前
lxj完成签到,获得积分10
9秒前
111完成签到 ,获得积分10
9秒前
qiang完成签到,获得积分10
9秒前
尊敬太阳完成签到,获得积分20
10秒前
molihuakai应助MoiMoi采纳,获得10
10秒前
eagle14835完成签到,获得积分10
10秒前
顺心抽屉完成签到 ,获得积分10
12秒前
勺子完成签到,获得积分10
13秒前
Epiphany完成签到,获得积分10
13秒前
科研通AI6.3应助DDvicky采纳,获得10
13秒前
黄豆完成签到,获得积分10
13秒前
六六发布了新的文献求助10
14秒前
小饼一定要上岸完成签到,获得积分10
14秒前
斯内克完成签到,获得积分10
15秒前
科研通AI6.3应助菲菲采纳,获得30
16秒前
云布布完成签到,获得积分10
16秒前
研友_LXdbaL完成签到,获得积分10
17秒前
17秒前
司马秋凌完成签到,获得积分10
17秒前
瘦洋洋发布了新的文献求助10
18秒前
学习通完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6951248
求助须知:如何正确求助?哪些是违规求助? 8635501
关于积分的说明 18310063
捐赠科研通 6393428
什么是DOI,文献DOI怎么找? 3082001
关于科研通互助平台的介绍 2127081
邀请新用户注册赠送积分活动 2058885